{
    "organizations": [],
    "uuid": "323b5d7881a0ab44c3e44b81c270b9e152016117",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-regulator-rejects-shenzhen-hepalin/brief-regulator-rejects-shenzhen-hepalink-pharmaceuticals-asset-acquisition-proposal-idUSH9N1P000J",
    "ord_in_thread": 0,
    "title": "BRIEF-Regulator Rejects Shenzhen Hepalink Pharmaceutical's Asset Acquisition Proposal",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 10 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd :\n* SAYS SECURITIES REGULATOR REJECTS ITS ASSET ACQUISITION PROPOSAL Source text in Chinese: bit.ly/2CO4z93 Further company coverage: (Reporting by Hong Kong newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-10T18:03:00.000+02:00",
    "crawled": "2018-01-11T12:33:41.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shenzhen",
        "hepalink",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "security",
        "regulator",
        "reject",
        "asset",
        "acquisition",
        "proposal",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "reporting",
        "hong",
        "kong",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}